blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2184058

EP2184058 - Drug coating providing high drug loading and methods for providing the same [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.12.2012
Database last updated on 05.05.2025
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ALZA Corporation
1900 Charleston Avenue, P.O. Box 7210
Mountain View, CA 94039 / US
[2011/36]
Former [2010/19]For all designated states
ALZA Corporation
1900 Charleston Road P.O. Box 7210
Mountain View, CA 94039-7210 / US
Inventor(s)01 / Cruz, Evangeline
3889 Blackstone Court
Hayward, CA 94542 / US
02 / Ruhlmann, Gregory
18600 Barnhart Avenue
Cupertino, CA 95014 / US
03 / Pollock, Brenda
7520 Kirwin Lane
Cupertino, CA 95014 / US
04 / Li, Sherry
20727 Garden Crest Court
Cupertino, CA 95014 / US
05 / Garcia, Carmelita
36342 Tunbridge Drive
Newark, CA 94560 / US
06 / Wong, Alfredo, M.
778 E. Homestand Road
Sunnyvale, CA 94087 / US
07 / Bronz, Ryan
931 Brookgrove Lane
Cupertino, CA 95014 / US
08 / Fink, Tracy
150 W. Rincon
Campbell, CA 95008 / US
09 / Edgren, David
277 N. Avalon Drive
Los Altos, CA 94022 / US
 [2012/06]
Former [2010/19]01 / Cruz, Evangeline
3889 Blackstone Court
Hayward, CA 94542 / US
02 / Ruhlmann, Gregory
18600 Barnhart Avenue
Cupertino, CA 95014 / US
03 / Pollock, Brenda
7520 Kirwin Lane
Cupertino, CA 95014 / US
04 / Li, Sherry
20727 Garden Crest Court
Cupertino, CA 95014 / US
05 / Garcia, Carmelita
36342 Tunbridge Drive
Newark, CA 94560 / US
06 / Wong, Alfredo, M.
778 E. Homestand Road
Sunnyvale, CA 94087 / US
07 / Bronz, Ryan
931 Brookgrove Lane
Cupertino, CA 95014 / US
08 / Fink, Tracy
150 W. Rincon
Campbell, CA 95008 / US
09 / Edgren, David
277 N. Avalon Drive
Los Altos, CA 94022 / US
Representative(s)Suèr, Steven Johannes, et al
Ablett & Stebbing
7-8 Market Place
London W1W 8AG / GB
[N/P]
Former [2010/19]Suèr, Steven Johannes, et al
Ablett & Stebbing Caparo House 101-103 Baker Street
London W1U 6FQ / GB
Application number, filing date10151011.323.09.2004
[2010/19]
Priority number, dateUS20030506195P26.09.2003         Original published format: US 506195 P
[2010/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2184058
Date:12.05.2010
Language:EN
[2010/19]
Type: B1 Patent specification 
No.:EP2184058
Date:08.02.2012
Language:EN
[2012/06]
Search report(s)(Supplementary) European search report - dispatched on:EP13.04.2010
ClassificationIPC:A61K9/20, A61K9/16, A61K9/28, A61K31/167, A61K31/165, A61K31/485, A61K9/48
[2011/36]
CPC:
A61K31/165 (EP,US); A61K9/28 (KR); A61K31/00 (EP,US);
A61K31/167 (EP,US); A61K31/485 (EP,US); A61K9/0004 (EP,US);
A61K9/1676 (EP,US); A61K9/20 (KR); A61K9/209 (EP,US);
A61K9/2886 (EP,US); A61K9/48 (KR); A61K9/4808 (EP,US);
A61P25/04 (EP); A61P29/00 (EP); A61K9/2086 (EP,US);
A61K9/5084 (EP,US) (-)
C-Set:
A61K31/165, A61K2300/00 (EP,US);
A61K31/167, A61K2300/00 (US,EP);
A61K31/485, A61K2300/00 (US,EP)
Former IPC [2010/19]A61K9/24, A61K9/36, A61K31/167, A61K31/485
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/19]
TitleGerman:Arzneistoffcoating mit hohem Wirkstoffanteil sowie Methoden zu dessen Herstellung[2010/20]
English:Drug coating providing high drug loading and methods for providing the same[2010/19]
French:Enrobage de médicaments à charge médicamenteuse élevée et procès de fabrication[2011/36]
Former [2010/19]Arzneimittelbeschichtung mit hoher Arzneimittelbeladung und Verfahren dafür
Former [2010/19]Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
Examination procedure12.11.2010Amendment by applicant (claims and/or description)
12.11.2010Examination requested  [2010/52]
29.12.2010Despatch of a communication from the examining division (Time limit: M06)
29.06.2011Reply to a communication from the examining division
11.07.2011Despatch of a communication from the examining division (Time limit: M01)
19.07.2011Reply to a communication from the examining division
17.08.2011Communication of intention to grant the patent
16.12.2011Fee for grant paid
16.12.2011Fee for publishing/printing paid
Parent application(s)   TooltipEP04821250.0  / EP1708684
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040821250) is  27.10.2006
Opposition(s)09.11.2012No opposition filed within time limit [2013/03]
Fees paidRenewal fee
18.02.2010Renewal fee patent year 03
18.02.2010Renewal fee patent year 04
18.02.2010Renewal fee patent year 05
18.02.2010Renewal fee patent year 06
14.09.2010Renewal fee patent year 07
08.09.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.09.2004
AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
TR08.02.2012
BG08.05.2012
GR09.05.2012
ES19.05.2012
PT08.06.2012
IE23.09.2012
LU23.09.2012
CH30.09.2012
LI30.09.2012
MC30.09.2012
[2014/34]
Former [2014/27]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
TR08.02.2012
BG08.05.2012
GR09.05.2012
ES19.05.2012
PT08.06.2012
IE23.09.2012
LU23.09.2012
CH30.09.2012
LI30.09.2012
MC30.09.2012
Former [2014/21]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
TR08.02.2012
BG08.05.2012
GR09.05.2012
ES19.05.2012
PT08.06.2012
IE23.09.2012
CH30.09.2012
LI30.09.2012
MC30.09.2012
Former [2013/33]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
BG08.05.2012
GR09.05.2012
ES19.05.2012
PT08.06.2012
IE23.09.2012
CH30.09.2012
LI30.09.2012
MC30.09.2012
Former [2013/22]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
GR09.05.2012
ES19.05.2012
PT08.06.2012
MC30.09.2012
Former [2013/20]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
GR09.05.2012
PT08.06.2012
MC30.09.2012
Former [2013/07]AT08.02.2012
BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/50]BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
IT08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
SK08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/49]BE08.02.2012
CY08.02.2012
CZ08.02.2012
DK08.02.2012
EE08.02.2012
FI08.02.2012
NL08.02.2012
PL08.02.2012
RO08.02.2012
SE08.02.2012
SI08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/48]BE08.02.2012
CY08.02.2012
EE08.02.2012
FI08.02.2012
NL08.02.2012
PL08.02.2012
SE08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/41]BE08.02.2012
CY08.02.2012
FI08.02.2012
NL08.02.2012
PL08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/37]BE08.02.2012
FI08.02.2012
NL08.02.2012
PL08.02.2012
GR09.05.2012
PT08.06.2012
Former [2012/36]NL08.02.2012
GR09.05.2012
Former [2012/35]NL08.02.2012
Documents cited:Search[Y]US4946685  (EDGREN DAVID E [US], et al) [Y] 1-13 * column 12, line 26 - line 29 * * examples 28,29 * * claim 1 * * column 7, line 3 - line 23 *;
 [A]WO9944591  (ALZA CORP [US]) [A] 1-13 * examples 2,3 *;
 [A]EP0958812  (FREUNT IND CO LTD [JP]) [A] 1-13* example 4 *;
 [Y]US2003092724  (KAO HUAIHUNG [US], et al) [Y] 1-13 * examples 1,2 * * claims 1-11,15,29 * * claims 21-27 *
by applicantUS4235236
 US4278087
 US4576604
 US4663149
 US4717569
 US4763405
 US4777049
 US4801461
 US4854470
 US4961932
 US5023088
 US5030456
 US5221536
 US5245357
 US5273760
 US5286493
 US5407686
 WO9534285
 WO9610996
 US5512299
 US5534263
 US5614578
 US5667804
 US5830502
 US5858407
 US5906832
 US5948747
 WO9955313
 US5998478
 US6004582
 US6020000
 WO0035426
 US6136345
 US6153678
 US6174547
 US6183466
 US6245357
 WO0151038
 US6316028
 US6365183
 US2002071863
 US2003198619
 US2003232078
 WO2004002448
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.